SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

Pfizer Inc. is a research-based global biopharmaceutical company, which engages in the discovery, development, manufacture, marketing, sales and distribution of biopharmaceutical products worldwide. The firm works across developed and emerging markets to advance wellness, prevention, treatments and cures that challenge the most feared diseases. The company was founded by Charles Pfizer Sr. and Charles Erhart in 1849 and is headquartered in New York, NY.

Pfizer Inc.

Pfizer Inc

Pfizers recent climb to a fresh yearly high and move back above a key round-number level is driving attention, with traders celebrating the breakout and bullish momentum. Others question whether the advance can hold, citing resistance, patent-cliff concerns and the lack of a clear new catalyst ahead of the quarterly report.

Eli Lilly & Co. engages in the discovery, development, manufacture, and sale of pharmaceutical products. The firm's products include diabetes, oncology, immunology, neuroscience, and other products and therapies. The company was founded by Eli Lilly on May 10, 1876 and is headquartered in Indianapolis, IN.

Lilly(Eli) & Co

Attention centers on expectations for Lillys upcoming quarterly report, with traders looking for continued Mounjaro and Zepbound growth and stronger guidance after a recent run to record highs. Bulls see momentum continuing, while skeptics argue expectations are elevated and debate whether oral GLP-1 competition from Novo and Foundayo could challenge Lillys lead.

AbCellera Biologics, Inc. engages in the development of therapeutic antibodies. It offers antibody discovery platform that searches, decodes and analyzes natural immune systems to find antibodies that can be developed to prevent and treat disease. The company was founded by Carl Lars G. Hensen, Kathleen Lisaingo, Kevin Heyries, Véronique Lecault and Daniel Da Costa on November 8, 2012 and is headquartered in Vancouver, Canada.

AbCellera Biologics Inc

Attention centers on ABCL635, AbCelleras investigational treatment for menopausal hot flashes: traders are weighing its positive Phase 2 results and additional clinical data presented at a menopause conference. The reaction is broadly bullish, reinforced by new analyst coverage, but some say the news may already be priced in and emphasize that further trials are needed to confirm the findings.

Papa John's International, Inc. engages in the operation and franchise of pizza delivery and carryout restaurants. It operates through the following segments: Domestic Company-owned Restaurants, North America Franchising, North America Commissaries, International Operations, and All Others. The Domestic Company-Owned Restaurants segment consists of retail sales of pizza and side items, breadsticks, cheese sticks, chicken poppers and wings, dessert items, and canned and bottled beverages. The North America Franchising segment involves the offering of sales and support activities, development rights, and collection of royalties from franchisees located in the United States and Canada. The North America Commissaries segment includes the eleven full-service regional dough production and distribution and quality control centers. The International Operations segment represents all restaurant operations outside of the United States and Canada. The All Others segment focuses on franchise contributions to marketing funds and sale, company-owned and franchised restaurants, information systems and related services used in restaurant operations, point-of-sale system, online and other technology-based ordering platforms, printing, and promotional items. The company was founded by John H. Schnatter in 1984 and is headquartered in Louisville, KY.

Papa John`s International, Inc.

A reported take-private bid involving Papa Johns largest U.S. franchisee has fueled renewed buyout speculation and a sharp rally. Traders are debating whether the board will accept or negotiate, while skeptics point to weak sales and the suspended dividend; no deal is confirmed.

Atlassian Corp. is a holding company, which engages in providing team collaboration and productivity software. Its products include Jira Software, Confluence, Jira Service Management, and Loom. The company was founded by Michael Cannon-Brookes and Scott Farquhar in October 2002 and is headquartered in San Francisco, CA.

Atlassian Corporation - Ordinary Shares - Class A

Atlassian Corporation Plc

A sharp rebound and breakout in Atlassian shares, supported by strong cloud growth and repeated analyst upgrades, has fueled bullish momentum and renewed optimism about software stocks ability to benefit from AI. Traders are divided over whether the move can continue or is overextended ahead of earnings, with some warning of a pullback and persistent concerns about valuation and AI disruption.

ExxonMobil Holdings Corp. is an international energy and petrochemical company, which creates solutions that improve quality of life and meets society’s evolving needs. The company is headquartered in Spring, TX.

ExxonMobil Holdings Corp.

Exxon Mobil Corp

Exxon is drawing attention as crude prices rise amid Middle East supply concerns and traders anticipate a strong refining contribution to its upcoming quarterly report. The community is debating whether refining strength can offset weaker upstream results and how long the margin boost will last.

Microsoft Corp. engages in the development and support of software, services, devices, and solutions. It operates through the following segments: Productivity and Business Processes, Intelligent Cloud, and More Personal Computing. The Productivity and Business Processes segment is composed of products and services relating to productivity, communication, and information services such as Office Commercial, Office Consumer, LinkedIn, and Dynamics business solutions. The Intelligent Cloud segment consists of public, private, and hybrid server products and cloud services for businesses and developers, as well as enterprise and partner services. The More Personal Computing segment refers to products and services including Windows operating system, Windows cloud services, Surface, HoloLens, personal computer accessories, Xbox hardware, Xbox Cloud Gaming, Microsoft News, and Microsoft Edge. The company was founded by Paul Gardner Allen and William Henry Gates, III in 1975 and is headquartered in Redmond, WA.

Microsoft Corporation

Microsoft Corp

Microsofts upcoming quarterly report is the dominant focus, with traders watching Azure growth and whether AI demand can justify rising data-center spending. Views are split between confidence in cloud and AI momentum and concern that heavy capex, delayed returns, and depreciation could pressure margins.

Petróleo Brasileiro SA engages in oil and gas exploration, production, and distribution activities. It operates through the following segments: Exploration and Production; Refining, Transportation, and Marketing; and Gas and Low Carbon Energies. The Exploration and Production segment covers the activities of exploration, development, and production of crude oil, natural gas liquid, and natural gas, for the primary purpose of supplying its domestic refineries. The Refining, Transportation, and Marketing segment refers to refining, logistics, transport, and trading of crude oil and oil products activities as well as exports of ethanol. The Gas and Low Carbon Energies represents the activities of logistic and trading of natural gas and electricity, transportation and trading of liquefied natural gas, generation and electricity by means of thermoelectric power plants, as well as holding interests in transporters and distributors of natural gas. The company was founded on October 3, 1953 and is headquartered in Rio de Janeiro, Brazil.

Petroleo Brasileiro S.A. Petrobras - ADR

Petroleo Brasileiro

Traders are focused on Brazils presidential runoff and the possibility of Flvio Bolsonaro winning, with speculation that a change in government could bring more shareholder-friendly policies and lift Petrobras shares. Bullish election positioning is tempered by uncertainty about the result and the risk of a sell-the-news reaction; higher oil prices are also supporting the discussion.

FMC Corp. is an agricultural sciences company, which engages in the provision of solutions to growers and development of pipeline in crop protection, plant health, agriculture, pest control, and turf management. It offers insect control products under the Rynaxypyr and Cyazypyr brands. The company was founded by John Bean in 1883 and is headquartered in Philadelphia, PA.

FMC Corp.

FMCs sharply reduced third-quarter outlook, driven by weak demand and price adjustments to clear excess distributor inventory, has intensified concern about its earnings, debt burden and potential bankruptcy risk. Bulls argue the reset is a one-time step toward recovery and point to debt-reduction efforts, while skeptics doubt the turnaround and warn of further financial distress.

Chevron Corp. engages in the provision of oil and gas energy solutions. It provides crude oil and natural gas, manufactures transportation fuels, lubricants, petrochemicals, and additives, and develops technologies that enhance business and the industry. It operates through the Upstream and Downstream segments. The Upstream segment consists of the exploration, development, and production of crude oil and natural gas, the liquefaction, transportation, and regasification associated with liquefied natural gas, the transporting of crude oil by major international oil export pipelines, the processing, transporting, storage, and marketing of natural gas, and a gas-to-liquids plant. The Downstream segment consists of the refining of crude oil into petroleum products, the marketing of crude oil and refined products, the transporting of crude oil and refined products by pipeline, marine vessel, motor equipment, and rail car, and the manufacturing and marketing of commodity petrochemicals and plastics for industrial uses and fuel & lubricant additives. The company was founded on September 10, 1879 and is headquartered in Houston, TX.

Chevron Corp.

Chevrons breakout to record highs is drawing attention, with traders pointing to firm crude prices and supply-risk concerns while positioning ahead of its earnings report. Sentiment is mostly bullish, though some question whether strong energy markets will last and whether the rally has already priced in the results.

statis crypto Watchlist

Bitcoin

Ethereum

Solana

Ripple

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

Wednesday 10/21 Insider Buying Report: BOLD, OWLS

As the saying goes, there are many possible reasons for an insider to sell a stock, but only one reason to buy -- they expect to make money. So let's look at two noteworthy recent insider buys.

On Tuesday, Boundless Bio's, Kevin Tang, made a $349,593 buy of BOLD, purchasing 14...

Are OPCH, PCRX, RXO, BOLD Obtaining Fair Deals for their Shareholders?

Are OPCH, PCRX, RXO, BOLD Obtaining Fair Deals for their Shareholders? Are OPCH, PCRX, RXO, BOLD Obtaining Fair Deals for their Shareholders?PR NewswireNEW YORK, Oct. 12, 2026Insiders may stand to receive substantial financial benefits not available to ordinary shareholders. The proposed...

SHAREHOLDER ALERT: The M&A Class Action Firm Continues to Investigate the Merger--ACA, APGE, BOLD, and GBCS

SHAREHOLDER ALERT: The M&A Class Action Firm Continues to Investigate the Merger--ACA, APGE, BOLD, and GBCS SHAREHOLDER ALERT: The M&A Class Action Firm Continues to Investigate the Merger--ACA, APGE, BOLD, and GBCS PR Newswire NEW YORK, July 2, 2026 NEW YORK, July 2, 2026 /PRNewswire/ -- Class...

Are TECH, APGE, BOLD, REFI Obtaining Fair Deals for their Shareholders?

Are TECH, APGE, BOLD, REFI Obtaining Fair Deals for their Shareholders? Are TECH, APGE, BOLD, REFI Obtaining Fair Deals for their Shareholders? PR Newswire NEW YORK, June 25, 2026 Insiders may stand to receive substantial financial benefits not available to ordinary shareholders. The proposed...

Why Did BOLD, BLZE, QNT Stocks Surge To 52-Week Highs Today 

Equity

Investors showed interest in businesses tied to artificial intelligence infrastructure, advanced biotechnology, and quantum computing.



$HAREHOLDER ALERT: The M&A Class Action Firm Announces An Investigation of Boundless Bio, Inc. (NASDAQ: BOLD)

$HAREHOLDER ALERT: The M&A Class Action Firm Announces An Investigation of Boundless Bio, Inc. (NASDAQ: BOLD) $HAREHOLDER ALERT: The M&A Class Action Firm Announces An Investigation of Boundless Bio, Inc. (NASDAQ: BOLD) PR Newswire NEW YORK, June 23, 2026 NEW YORK, June 23, 2026 /PRNewswire...

BOLD Stock Is Up 90% — Here's What's Behind The Biggest Rally In Company History

Boundless Bio is set to merge with Serapha Bio, with the transaction set to close in the fourth quarter of 2026.

BOLD Stock Alert: Halper Sadeh LLC is Investigating Whether Boundless Bio, Inc. is Obtaining a Fair Price for its Shareholders

Halper Sadeh LLC, an investor rights law firm, is investigating the merger of Boundless Bio, Inc. (NASDAQ: BOLD) and Serapha Bio, Inc. Upon closing of the proposed transaction, Boundless Bio shareholders are expected to own approximately 3.7% of the combined company.Halper Sadeh encourages...

Market Movers Catching Transformational Catalysts

Today’s common theme is scale. Whether through regulatory advancement, access to new capital, expanding commercial opportunities, or technological innovation, companies that successfully execute during periods of rapid change often find themselves at important inflection points. $NTHI, $BOLD, $BLZE, $CRWV, $PLTR, $ZETA, $ATLN, $HSCS

Big Money Backs Base Editing, as BOLD Deal Creates Well-Funded AATD Contender

The biotechnology sector continues to reward companies developing potentially transformative genetic medicines, particularly those addressing serious diseases with limited treatment options. The latest example emerged as Boundless Bio (NASDAQ:BOLD) announced a merger agreement with privately held Serapha Bio, a clinical-stage gene editing company developing an investigational treatment for Alpha-1 Antitrypsin Deficiency (AATD), alongside a substantial $230 million private financing commitment from a syndicate of prominent healthcare investors.

Boundless Bio, Inc. is a clinical-stage oncology company, which is dedicated to unlocking a new paradigm in cancer therapeutics that addresses the significant unmet need in patients with oncogene amplified tumors by targeting extrachromosomal DNA. The company was founded by Vineet Bafna, Paul Mischel, Benjamin F. Cravatt, and Jonathan E. Lim on April 10, 2018 and is headquartered in La Jolla, CA.

Boundless Bio Inc.

Bearish Sentiment

<ul class="summary-bullets"><li>Boundless Bio shares reached a 52-week high of $2.75 after the company agreed to merge with private biotech firm Serapha Bio.</li><li>Backblaze shares climbed to a two-year high of $11.85 after the company announced a $335 million, five-year storage deal with CoreWeave.</li><li>Quantinuum shares hit a record high of $81.48 after a White House executive order supported U.S. quantum technology development.&nbsp;</li></ul>Shares of Boundless Bio (BOLD), Backblaze (BLZE) and quantum computing company Quantinuum (QNT) climbed to fresh 52-week highs on Tuesday as investors poured capital into specialized technology and life sciences companies benefiting from major corporate and policy developments.While&nbsp;<a href="https://stocktwits.com/symbol/BOLD">Boundless Bio</a> and&nbsp;<a href="https://stocktwits.com/symbol/BLZE">Backblaze</a> stocks surged 85% and 43%, respectively,&nbsp;<a href="https://stocktwits.com/symbol/QNT">Quantinuum stock</a> gained over 13%.&nbsp;<h2 class="st-heading-2">BOLD Reinvents Itself Through Merger</h2>In biotechnology, Boundless Bio stock hit a 52-week high of $2.75 after agreeing to&nbsp;<a href="https://stocktwits.com/news-articles/markets/equity/bold-stock-surges-on-merger-news/cZKw9bzR7aD">combine</a> with privately held Serapha Bio in an all-stock transaction. The merged company plans to focus on developing clinical-stage base-editing treatments.The merged company will concentrate on advancing SERP-01, an investigational treatment designed to correct the genetic mutation most commonly responsible for severe Alpha-1 Antitrypsin Deficiency (AATD).&nbsp;The deal also includes $230 million in funding from healthcare investors, giving the company money to advance its drug development and clinical trials. Investors viewed the transaction as a major shift that positions Boundless Bio as a stronger player in the gene-editing space.On Stocktwits, retail sentiment around the stock improved to ‘extremely bullish’ from ‘neutral’ territory the previous day.&nbsp;<h2 class="st-heading-2">BLZE Lands Major AI Infrastructure Opportunity</h2>Backblaze stock reached a two-year high of $11.85 after unveiling a five-year&nbsp;<a href="https://stocktwits.com/news-articles/markets/equity/blze-stock-surges-after-storage-deal-with-core-weave-retail-bulls-call-backblaze-an-emerging-ai-cloud-contender/cZKwPxSR7aQ">agreement</a> valued at approximately $335 million with AI cloud provider CoreWeave (CRWV). The arrangement positions Backblaze as a key storage provider supporting large-scale AI workloads.&nbsp;Following the update, William Blair upgraded Backblaze to Market Perform from Underperform and described the CoreWeave partnership as a transformative development.&nbsp;The firm suggested the agreement offers strong evidence that enterprise customers view Backblaze's hard-disk-drive-based storage platform as a valuable component of large-scale AI operations. According to the analyst, the announcement addresses previous concerns about the company's ability to defend its market position and execute its strategy in the AI era.Retail sentiment around the stock jumped to ‘extremely bullish’ from ‘bearish’ territory the previous day.&nbsp;<h2 class="st-heading-2">Quantum Policy Boosts QNT</h2>Quantinuum also attracted significant attention after reaching a record high of $81.48, boosted by a White House executive order to ramp up U.S. quantum technology development.&nbsp;The U.S. government aims to build a quantum computer for scientific research by 2028 and expand quantum sensors and communication networks over the following years.&nbsp;Also, Federal agencies must upgrade their cybersecurity systems to use quantum-resistant encryption by 2031. This is intended to protect sensitive government data from future quantum computers that could potentially crack today's encryption methods.Retail sentiment around the stock remained in ‘bearish’ territory.&nbsp;So far this year BOLD and BLZE stocks have surged 116% and 150%, respectively. QNT stock has gained 28% since its June 4 debut.&nbsp;Also See:&nbsp;<a href="https://stocktwits.com/news-articles/markets/equity/trib-qtrx-rcon-why-these-stocks-are-surging-after-hours-today/cZKUM3NR7O7">TRIB, QTRX, RCON: Why These Stocks Are Surging After-Hours Today</a>For updates and corrections, email newsroom[at]stocktwits[dot]com.

The new Crispr Therapeutics Tissue Culture Lab. 

Shares of Boundless Bio (BOLD), Backblaze (BLZE) and quantum computing company Quantinuum (QNT) climbed to fresh 52-week highs on Tuesday as investors poured capital into specialized technology and life sciences companies benefiting from major corporate a

Backblaze Inc - Ordinary Shares - Class A

CoreWeave Inc

Quantinuum Inc.

Up more than 1%

Flat to up 1%

Flat to down 1%

Down more than 1%

What do you think the S&amp;P 500&#39;s ($SPY) return will be next week?

Current Price	$2.36
Prev Close	$2.44
Open	$2.41
Dividend Yield	0.00%
50-Day Moving Average	$2.70
Beta	1.19
Avg. Volume	131,689.12
PE Ratio	-0.83

52-Week High	$3.16
52-Week Low	$0.9612
Market Capitalization	$53.69M
EPS (Annual)	-$2.60
Price to Book	0.80
Revenue Per Employee	$0.00

Feed

News

Sentiment

Earnings

Fundamentals

Info

BOLD Fundamentals